Хайлтын үр дүнгүүд - Sigrun Halvorsen
- 85-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease -н Jarle Jortveit, Sigrun Halvorsen, Anete Kaldal, Are Hugo Pripp, Ragna Elise Støre Govatsmark, Jørund Langørgen
Хэвлэсэн 2019Artigo -
10
-
11
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants -н Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, Pål Falck, Oddvar Solli, Christian Jonasson
Хэвлэсэн 2016Artigo -
12
Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction -н Vibeke Ritschel, Ingebjørg Seljeflot, Harald Arnesen, Sigrun Halvorsen, Jan Eritsland, Morten Wang Fagerland, Geir Øystein Andersen
Хэвлэсэн 2016Artigo -
13
Rapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation study -н Tonje R. Johannessen, Sven Eirik Ruud, Anne Cecilie K. Larstorp, Dan Atar, Sigrun Halvorsen, Beate Nilsen, Odd Martin Vallersnes
Хэвлэсэн 2025Artigo -
14
Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients -н Gemma Chiva‐Blanch, Vibeke Bratseth, Vibeke Ritschel, Geir Øystein Andersen, Sigrun Halvorsen, Jan Eritsland, Harald Arnesen, Lina Badimón, Ingebjørg Seljeflot
Хэвлэсэн 2016Artigo -
15
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups -н Georg Gelbenegger, Marek Postuła, Ladislav Pecen, Sigrun Halvorsen, Maciej Lesiak, Christian Schoergenhofer, Bernd Jilma, Christian Hengstenberg, Jolanta M. Siller‐Matula
Хэвлэсэн 2019Revisão -
16
-
17
-
18
Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC)... -н Florian Schlotter, Kurt Huber, Christian Hassager, Sigrun Halvorsen, Pascal Vranckx, Janine Pöss, Konstantin A. Krychtiuk, Roberto Lorusso, Nikolaos Bonaros, Patrick A. Calvert, Matteo Montorfano, Hölger Thiele
Хэвлэсэн 2024Revisão -
19
The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial -н Roopinder K. Sandhu, Justin A. Ezekowitz, Ulrika Andersson, John H. Alexander, Christopher B. Granger, Sigrun Halvorsen, Michael Hanna, Ziad Hijazi, Petr Janský, Renato D. Lópes, Lars Wallentin
Хэвлэсэн 2016Artigo -
20
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC coun... -н Sofie Gevaert, Sigrun Halvorsen, Peter Sinnaeve, Antonia Sambola, Geeta Gulati, Patrizio Lancellotti, Peter van der Meer, Alexander R. Lyon, Dimitrios Farmakis, Geraldine Lee, Giuseppe Boriani, Ashutosh Wechalekar, Alicia Okines, Riccardo Asteggiano
Хэвлэсэн 2021Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Cardiology
Myocardial infarction
Intensive care medicine
Atrial fibrillation
Acute coronary syndrome
Percutaneous coronary intervention
Engineering
Mechanical engineering
Stroke (engine)
Warfarin
Disease
Confidence interval
Hazard ratio
Pathology
Randomized controlled trial
Heart failure
Rivaroxaban
Apixaban
Clinical endpoint
Antithrombotic
Aspirin
Medical emergency
Political science
Cholesterol
Law
Alternative medicine
Apolipoprotein A1
Conventional PCI